Galvanize Therapeutics today announced a three-way merger and $100 million in funding for its pulsed electric field (PEF) technology.
Life sciences venture capital firm Apple Tree Partners (ATP) created and incubated Galvanize. Initially, three companies — Gala Therapeutics, Galaxy Medical and Galvanize — comprised the incubation. They recently merged into one firm under the Galvanize name.
The company develops the Aliya PEF energy platform. It designed it for the treatment of chronic bronchitis symptoms, cardiac arrhythmias and solid tumors. There is also potential in the drug delivery space.
San Carlos, California-based Galvanize raised $100 million in its Series B financing round. Fidelity Management & Research Company led the funding round with participation from Intuitive Surgical, ATP and Gilmartin Capital.
“We are energized by this vote of confidence from our investors in our technology platform and team as we seek to bring transf…